Xeris Biopharma Reports Second Quarter 2023 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. BILL
4. MRK
5. MRNA
6. LOW
7. ADI
8. COTY
9. RARE
10. TJX

Go back to Xeris Biopharma Reports Second Quarter 2023 Financial Results
(NASDAQ: XERS) Delayed: 8.78 --0 (-0%)
Previous Close $8.78    52 Week High $ 
Open $8.78    52 Week Low $ 
Day High $8.78    P/E N/A 
Day Low $8.78    EPS $ 
Volume 24,065